Birmingham University is set to take part in a a new trial stromal cell immunotherapy for chronic liver disease.
Up to 56 patients are being recruited to take part in the MERLIN trial, which will investigate the safety and efficacy of a new cellular immunotherapy in patients with either Primary Sclerosing Cholangitis (PSC) or Autoimmune Hepatitis (AIH).
For further information, please use the following link: birmingham.ac.uk/news/lates...